Skip to main content
Revista Española de Quimioterapia logoLink to Revista Española de Quimioterapia
letter
. 2021 Oct 5;34(6):675–678. doi: 10.37201/req/067.2021

Septic arthritis caused by Bacteroides thetaiotaomicrom: A case report and review

David Brandariz-Núñez 1,, Jessica Gálvez-López 2
PMCID: PMC8638754  PMID: 34607418

Sir,

The septic arthritis is an uncommon infection with an incidence of 4 to 12/100,000 person-years. This complication is characterized by the rapid destruction of the joint with loss of function, because of hematogenous spread or direct inoculation of bacteria into the joint [1]. Septic arthritis of the knee is the most frequent location, with catastrophic sequelae and significant associated morbidity and mortality. Arthroscopic surgery and intra-articular injections represent two associated risk factors [2,3]. Polymicrobial etiology is uncommon, with the presence of coagulase-negative staphylococci (CNS) and Staphylococcus aureus, as the main microorganisms involved [4]. In turn, anaerobic bacteria are less common and are related to septic arthritis located in small joints, such as the wrist [5]. Most of the anaerobic microorganisms that cause arthritis are located in the intestinal tract and the origin of the infection is usually by hematogenous spread [6].

We describe the first case of anaerobic septic knee arthritis associated to Bacteroides thetaiotaomicrom in a patient after arthroscopic surgery and periodic knee infiltrations.

A 33-year-old male patient, who underwent reconstruction of the anterior cruciate ligament (ACL) of his left knee in 2015 in Italy. Since then, he has received hyaluronic acid injections every 6 months until the end of 2019. Since mid-February 2020, he had marked inflammation and recurrent joint effusion, requiring 2 evacuating arthrocentesis per week. On March 25, 2020, he came to our center with a fever and persistent effusion in the joint. A magnetic resonance imaging (MRI) was performed where abundant global synovitis and posterior extra-articular edema were observed. Synovial fluid was obtained for analysis and cultivation by arthrocentesis. The joint fluid analysis showed 41,627 leukocytes/mcl, 93.6% neutrophils and without the presence of crystals. No bacterial growth was observed after 5 days of incubation. The patient’s general biochemistry revealed an erythrocyte sedimentation rate (ESR) of 37 mm/h and a C-reactive protein (CRP) of 3 mg/dl. The following day, arthroscopic intervention for debridement and cleaning was decided, and empiric antimicrobial therapy was started with vancomycin 1g/12h and ceftazidime 2g/8h intravenous. Four samples of synovial exudate extracted during the surgical intervention were sent to culture. Two samples were incubated in conventional plate culture, without microbial growth after five days.

Two subcultures were performed for aerobic and anaerobic organisms from a liquid medium and incubated at 35° C in an environment containing 5% CO2 and anaerobic chamber, respectively. The incubation system was Bact/Alert® (BioMérieux) for five days. in one of the anaerobic samples, the system detected microbial growth after 16 hours of incubation. The anaerobic sample was seeded in medium Schaedler agar (SCS) observing microbial growth, under anaerobic conditions. B. thetaiotaomicrom was identified using the matrix-assisted laser desorption ionization time of flight mass spectrometry system (MALDI-TOF MS, VITEK MS®, BioMérieux). The susceptibility test was performed with the VITEK 2XL® system (BioMérieux). Antibiogram for B. thetaiotaomicrom is shown in table 1. Antimicrobial treatment was modified to piperacillin-tazobactam 4.5g/8h. After 2 weeks of intravenous antimicrobial treatment, the patient was completely afebrile, with a normalized PCR (0.5 mg/dl) and ESR (18 mm/h), with a flexion of the joint of 110°, without effusion, with moderate residual synovitis, mild bone edema and no intra-articular collections on MRI. Hospital discharge was decided with sequential antimicrobial therapy with metronidazole 500 mg/8h, for 2 weeks. A follow-up MRI was performed in July, showing complete resolution of the synovitis and edema. The patient returns to professional activity in October fully recovered.

Table 1.

Antibiogram of Bacteroides thetaiotaomicron

Antimicrobial MIC (mg/L) Susceptibility
Amoxicillin-clavulanic 0.25 S
Clindamycin >256 R
Imipenem 0.12 S
Metronidazole 0.25 S
Cefoxitin - R
Chloramphenicol - R
Piperacillin-tazobactam - S

MIC: minimum inhibitory concentration, R: resistant, S: susceptible

Anaerobic etiology in septic arthritis of the native joints is infrequent. Despite everything, cases of knee infection caused by Bacteroides fragilis group have been documented [7,8]. To our knowledge, this is the first case septic arthritis with isolation of B. thetaiotaomicrom. It is an anaerobic, aerotolerant, gram negative, non-sporulated bacillus that is part of the human commensal flora, present in the gastrointestinal and genitourinary tract [9,10]. B. thetaiotaomicrom has been described as a pathogen in infections mainly of abdominal origin, post-surgical, meningitis and otitis. It is a very rare anaerobic, all cases reported in the literature are shown in table 2 [11-24]. The presence of concomitant chronic pathologies in more than half of the collected patients may suggest an opportunistic behavior of B. thetaiotaomicrom. About the susceptibility profile, an increase in antimicrobial resistance has been reported in the Bacteroides fragilis group in the last two decades [25]. Clindamycin was classically considered the treatment of choice for infections caused by anaerobes. However, the degree of resistance to clindamycin in a study carried out in 13 European countries with 824 clinical isolates has risen to 28-60% in the Bacteroides fragilis group and specifically to 41% in B. thetaiotaomicrom [26]. Therefore, clindamycin should not be recommended as empirical treatment in infections caused by B. fragilis group. In respect of the family of beta-lactams and carbapenems, the emergence of resistance to piperacillin-tazobactam and to a lesser extent to meropenem and imipenem has also been described [26, 27]. metronidazole, resistance is extremely rare, with only two cases reported in the literature for B. thetaiotaomicrom. It is associated with the acquisition of Nim D genes located on chromosomes or plasmids. Resistance rates in the B. fragilis group are less than 1% in studies with multiple clinical isolates [18,21,26]. This reduction in the antimicrobial susceptibility confirms the need to always perform susceptibility tests on isolates of Bacteroides fragilis group, since it cannot be assumed that beta-lactams, carbapenems, and metronidazole will always be valid options.

Table 2.

Literature review of Bacteroides thetaiotaomicron cases.

Year/author Age/Sex Underlying condition Type of infection Antibiogram of Bacteroides thetaiotaomicron Antimicrobial treatment Evolution
Susceptible Resistant
1990
Patey [11]
51/Female Surgery for a genital and rectal prolapse 3 months before Polymicrobial meningitis - Thiophenicol and metronidazole Recovery
1996
Funada [12]
42/Female Acute lymphocytic leukemia Polymicrobial sepsis (neutropenic enterocolitis) Imipenem Gentamicin and ceftazidime Imipenem Exitus (massive GIB)
2003
Matsukawa [13]
68/Male Hepatitis C, alcohol abuser whit hepatic cirrhosis Polymicrobial sepsis - Imipenem Clinic improvement
2005 Feuillet [14] 45/Male Hearing loss and otorrhea for many years. Cholesteatoma and meningitis Amoxicillin- clavulanic, imipenem, metronidazole and clindamycin Penicillin G, cefotetan and vancomycin Amoxicillin-clavulanic and metronidazole Negative CSF culture and clinic improvement
2006 Miragliotta [15] 44/Female Uterine fibromyoma Post-surgical infection Amoxicillin- clavulanic, imipenem, metronidazole and moxifloxacin Amoxicillin, piperacillin-tazobactam and cefoxitin. Teicoplanin, imipenem and metronidazole Clinic improvement
2012
Faur [16]
46/Male Peritoneal dialysis due to kidney failure secondary to cystic kidney disease Peritonitis - Amikacin, vancomycin and metronidazole oral Negative peritoneal dialysis fluid culture and clinical improvement
2013
Chao [17]
86/Male Peritoneal dialysis Peritonitis Chloramphenicol and metronidazole Clindamycin and penicillin Metronidazole Recovered completely
2013
Toprak Ülger [18]
62/Male Head pancreas adenocarcinoma Post-surgical bacteremia Carbapenems and ampicillin-sulbactam Metronidazole Ampicillin-sulbactam Clinic improvement
2014
Agarwal [19]
56/Male Disseminated multiple myeloma Posterior spinal wound infection - Daptomycin, piperacillin-tazobactam and metronidazole Cure
2014
Kim [20]
60/Male Diabetes mellitus Polymicrobial mycotic aneurism - Metronidazole -
2015
Sadarangani [21]
43/Male Sigmoid diverticulitis Post-surgical intra- abdominal collection Tigecycline Clindamycin, piperacillin- tazobactam, ertapenem, meropenem and metronidazole Tigecycline Clinic improvement
2016
Nkamga [22]
41/Male None Chronic paravertebral muscle abscess - Metronidazole Cure
2019
kalay [23]
16/Male None Polymicrobial meningitis - Metronidazole and meropenem Negative CSF culture and clinic improvement
2020 Kanaujia [24] 15/Male None Recurrent otitis media Metronidazole, piperacillin- tazobactam, chloramphenicol and imipenem Clindamycin and cefoxitin Metronidazole Clinic improvement and cure

GIB: gastrointestinal bleeding, CSF: cerebrospinal fluid

Knee arthroscopy is a common and relatively safe procedure, with an infection rate that varies depending on the series from 0.0009 to 0.4% [28]. Age <50 years, male sex, diabetes, tobacco, complex interventions, and morbid obesity were identified as risk factors related to post-intervention knee infection [29]. Our patient underwent arthroscopic surgery in 2016; therefore, it seems little to proclaim that his septic arthritis is a direct consequence of the intervention. On the other hand, periodic infiltrations may be the main cause of infection. The association between septic arthritis of the knee and the intra-articular administration of corticosteroids is well demonstrated, whereas the injection of hyaluronic acid has not yet been, even though there are cases described in the literature [3, 30]. The treatment of septic arthritis consists of immobilizing the joint, draining the infected synovial fluid to obtain good control of the infection, and carrying out appropriate antimicrobial treatment with the appropriate duration [31].

In conclusion, septic knee arthritis is an infectious complication that can leave serious consequences. Our patient being the first described case of anaerobic septic arthritis associated with B. thetaiotaomicrom. The emerging resistance of B. thetaiotaomicrom to carbapenems and metronidazole implies the need to routinely identify and perform susceptibility tests on anaerobic bacteria such as B. fragilis group for adequate treatment.

FUNDING

None to declare

CONFLICTS OF INTEREST

The authors declare no conflict of interest.

References

  • 1.Mathews CJ, Weston VC, Jones A, Field M, Coakley G. Bacterial septic arthritis in adults. Lancet. 2010;375:846-55 DOI: 10.1016/S0140-6736(09)61595-6 [DOI] [PubMed] [Google Scholar]
  • 2.Balato G, Di Donato SL, Ascione T, D’Addona A, Smeraglia F, Di Vico G, Rosa D. Knee Septic Arthritis after Arthroscopy: Incidence, Risk Factors, Functional Outcome, and Infection Eradication Rate. Joints. 2017;5:107-13 DOI: 10.1055/s-0037-1603901 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Xu C, Peng H, Li R, Chai W, Li X, Fu J, Liu K, Yu B, Jia C, Chen J. Risk factors and clinical characteristics of deep knee infection in patients with intra-articular injections: A matched retrospective cohort analysis. Semin Arthritis Rheum. 2018;47:911-16 DOI: 10.1016/j.semarthrit.2017.10.013 [DOI] [PubMed] [Google Scholar]
  • 4.Futterman O, Lieber SB, Nasrullah K, Fowler ML, Shmerling RH, Paz Z. Clinical characteristics of patients with polymicrobial septic arthritis. Eur J Clin Microbiol Infect Dis. 2019;38:1327–1332 DOI: 10.1007/s10096-019-03557-4 [DOI] [PubMed] [Google Scholar]
  • 5.McBride S, Mowbray J, Caughey W, Wong E, Luey C, Siddiqui A. Epidemiology, Management, and Outcomes of Large and Small Native Joint Septic Arthritis in Adults. Clin Infect Dis. 2020;70:271-79 DOI: 10.1093/cid/ciz265 [DOI] [PubMed] [Google Scholar]
  • 6.S Snydman DR, Jacobus NV, McDermott LA, Golan Y, Goldstein EJ, Harrell L, Jenkins S, Newton D, Pierson C, Rosenblatt J, Venezia R, Gorbach SL, Queenan AM, Hecht DW. Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009. Anaerobe. 2011;17(4):147-51. DOI: 10.1016/j.anaerobe.2011.05.014. [DOI] [PubMed] [Google Scholar]
  • 7.Dubost JJ, Couderc M, Tatar Z, Tournadre A, Lopez J, Mathieu S, Soubrier M. Three-decade trends in the distribution of organisms causing septic arthritis in native joints: single center study of 274 cases. Joint Bone Spine 2014;81:438-40 DOI: 10.1016/j.jb-spin.2014.05.001 [DOI] [PubMed] [Google Scholar]
  • 8.Nolla JM, Murillo O, Narvaez J, Vaquero CG, Lora-Tamayo J, Pedrero S, Cabo J, Ariza J. Pyogenic arthritis of native joints due to Bacteroides fragilis: Case report and review of the literature. Medicine (Baltimore). 2016;95(25):e3962 DOI: 10.1097/MD.0000000000003962 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jousimies-Somer HR, Summanen PH, Wexler H, Finegold SM, Gharbia SE, Shah NH. Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and other anaerobic Gram-negative bacteria. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MH, Yolken RY, editors. Manual of Clinical Microbiology. Washington DC: ASM Press; 2003. p. 880–901. [Google Scholar]
  • 10.Lorber B. Bacteroides, Prevotella, Porphyromonas, and Fusobacterium species (and other medically important anaerobic Gram-negative bacilli). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Philadelphia, PA: Churchill Livingstone Inc; 2005. p. 2838–46. [Google Scholar]
  • 11.Patey O, Breuil J, Fisch A, Burnat C, Vincent-Ballereau F, DuBlanchet A. Bacteroides fragilis meningitis: report of two cases. Rev Infect Dis. 1990;12:364-5 DOI: 10.1093/clinids/12.2.364 [DOI] [PubMed] [Google Scholar]
  • 12.Funada H, Shirasaki H, Matsuda T, Akasofu M. Rhabdomyolysis complicating polymicrobial sepsis in a patient with acute leukemia. Intern Med. 1996;35:36–8 DOI: 10.2169/internalmedicine.35.36 [DOI] [PubMed] [Google Scholar]
  • 13.Matsukawa Y, Kitamura N, Kaneko M, Yoshioka D, Miki T, Nishinarita S, et al. Multibacterial sepsis in an alcohol abuser with hepatic cirrhosis. Intern Med 2003;42:208–10 DOI: 10.2169/internalmedicine.42.208 [DOI] [PubMed] [Google Scholar]
  • 14.Feuillet L, Carvajal J, Sudre I, Pelletier J, Thomassin JM, Drancourt M, et al. First isolation of bacteroides thetaiotaomicron from a patient with a cholesteatoma and experiencing meningitis. J Clin Microbial. 2005;43:1467–9 DOI: 10.1128/JCM.43.3.1467-1469.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Miragliotta G, Del Gaudio T, Tajani E, Mosca A. Bacteroides thetaiotaomicron in posthysterectomy infection. Anaerobe. 2006;12:276–8 DOI: 10.1016/j.anaerobe.2006.07.002 [DOI] [PubMed] [Google Scholar]
  • 16.Faur D, García-Méndez I, Martí-Alemany N, Vallès-Prats M. Monomicrobian peritonitis by Bacteroides thetaiotaomicron in perito-neal dialysis patient. Nefrología. 2012;32:694 DOI: 10.3265/Nefrologia.pre2012.Jun.11568 [DOI] [PubMed] [Google Scholar]
  • 17.Chao C, Liu W, Lai C. Peritoneal Dialysis Peritonitis Caused by Bacteroides thetaiotaomicron. Perit Dial Int. 2013;33: 711–12 DOI: 10.3747/pdi.2012.00229 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Toprak Ülger N, Sayin E, Soyad A, Dane F, Soyletir G. The first metronidazole-resistant Bacteroides species isolated at Mamara University Hospital: Bacteroides thetaiotaomicron. Microbiyol Bul. 2013;47:717-21. (In Turkish) DOI: 10.5578/mb.5064 [DOI] [PubMed] [Google Scholar]
  • 19.Agarwal N, Hansberry D, Goldstein I. Infection with Bacteroides thetaiotaomicron during posterior decompression and dynamic stabilization of the lumbar spine: a case report and review of the literature. Int J Neurosci. 2014;124:621-25 DOI: 10.3109/00207454.2013.865618 [DOI] [PubMed] [Google Scholar]
  • 20.Kim MG, Jeon JW, Ryu IH, Lee JJ, Kim JS, Choi JW, Cho BS, Yoon HJ. Mycotic abdominal aortic aneurysm caused by Bacteroides thetaiotaomicron and Acinetobacter lwoffii: the first case in Korea. Infect Chemother. 2014;46:54-8 DOI: 10.3947/ic.2014.46.1.54 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.S.P. Sadarangani, S.A. Cunningham, P.R. Jeraldo, J.W. Wilson, R. Khare, R. Patel, Metronidazole-and carbapenem-resistant Bacteroides thetaiotaomicron isolated in rochester, Minnesota, in 2014. Antimicrob Agents Chemother. 2015;59:4157-61 DOI: 10.1128/AAC.00677-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Nkamga VD, Lotte R, Roger PM, Drancourt M, Ruimy R. Methanobrevibacter Smithii and Bacteroides Thetaiotaomicron Cultivated From a Chronic Paravertebral Muscle Abscess. Clin Microbiol Infect. 2016;22:1008-9 DOI: 10.1016/j.cmi.2016.09.007 [DOI] [PubMed] [Google Scholar]
  • 23.Kalay GN, Dalgic N, Bozan T, Ulger-Toprak T, Bayraktar B, Soyletir G. Polymicrobial anaerobic meningitis caused by Bacteroides fragilis, Bacteroides thetaiotaomicron, Fusobacterium necrophorum and Slackia exigua in a patient with mastoiditis following otitis media. Anaerobe. 2019;56:95-7 DOI: 10.1016/j.anaerobe.2019.02.003 [DOI] [PubMed] [Google Scholar]
  • 24.Kanaujia R, Gupta S, Singla N, Jani P, Angrup A. A child with recurrent otitis media due to Bacteroides thetaiotaomicron. Anaerobe. 2020;63:102203. DOI: 10.1016/j.anaerobe.2020.102203 [DOI] [PubMed] [Google Scholar]
  • 25.Hansen KC, Schwensen SA, Henriksen DP, Justesen US, Sydenham TV. Antimicrobial resistance in the Bacteroides fragilis group in faecal samples from patients receiving broad-spectrum antibiotics. Anaerobe 2017;47:79–85 DOI: 10.1016/j.anaerobe.2017.04.013 [DOI] [PubMed] [Google Scholar]
  • 26.Nagy E, Urbán E, Nord CE; ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin Microbiol Infect. 2011;17(3):371-379 DOI: 10.1111/j.1469-0691.2010.03256.x [DOI] [PubMed] [Google Scholar]
  • 27.Snydman DR, Jacobus NV, McDermott LA, Golan Y, Goldstein EJ, Harrell L, Jenkins S, Newton D, Pierson C, Rosenblatt J, Venezia R, Gorbach SL, Queenan AM, Hecht DW. Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009. Anaerobe 2011;17:147–151 DOI: 10.1016/j.anaerobe.2011.05.014 [DOI] [PubMed] [Google Scholar]
  • 28.Balato G, Di Donato SL, Ascione T, D’Addona A, Smeraglia F, Di Vico G, Rosa D. Knee Septic Arthritis after Arthroscopy: Incidence, Risk Factors, Functional Outcome, and Infection Eradication Rate. Joints. 2017. Jul 28;5(2):107-113 DOI: 10.1055/s-0037-1603901 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Clement RC, Haddix KP, Creighton RA, Spang JT, Tennant JN, Kamath GV. Risk factors for infection after knee arthroscopy: analysis of 595,083 cases from 3 United states databases. Arthroscopy 2016; 32 (12):2556-2561 DOI: 10.1016/j.arthro.2016.04.026 [DOI] [PubMed] [Google Scholar]
  • 30.Shemesh S, Heller S, Salai M, Velkes S. Septic arthritis of the knee following intraarticular injections in elderly patients: report of six patients. Isr Med Assoc J. 2011;13(12):757-760. [PubMed] [Google Scholar]
  • 31.Mathews CJ, Kingsley G, Field M, et al. Management of septic arthritis: a systematic review. Ann Rheum Dis 2007;66:440–5 DOI: 10.1136/ard.2006.058909 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Revista Española de Quimioterapia are provided here courtesy of Sociedad Española de Quimioterapia

RESOURCES